Molecule Details
| InChIKey | DMJWENQHWZZWDF-PKOBYXMFSA-N |
|---|---|
| Compound Name | Ecopipam |
| Canonical SMILES | CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.88 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12273 |
|---|---|
| Drug Name | Ecopipam |
| CAS Number | 112108-01-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Ecopipam has been used in trials studying the treatment of Tourette's Syndrome, Lesch-Nyhan Disease, Pathological Gambling, and Self-injurious Behavior. |
Categories: Antipsychotic Agents Central Nervous System Agents Central Nervous System Depressants Dopamine Agents Dopamine Antagonists Heterocyclic Compounds, Fused-Ring Neurotoxic agents Neurotransmitter Agents Psychotropic Drugs Tranquilizing Agents
Cross-references: BindingDB: 50004823 ChEBI: 93645 CHEMBL298406 ChemSpider: 97053 PubChem:107930 PubChem:347828544 Wikipedia: Ecopipam ZINC: ZINC000000003897
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P21728 | DRD1 | D(1A) dopamine receptor | modulator | targets |